BVF PARTNERS L P/IL Insider Trading $PIRS PIERIS PHARMACEUTICALS, INC.
Get free email notifications about insider trading for BVF PARTNERS L P/IL.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of BVF PARTNERS L P/IL. BVF PARTNERS L P/IL is in Capstone Therapeutics Corp. ($CAPS) and 10% Owner in CTI BIOPHARMA CORP ($CTIC) and Director in CTI BIOPHARMA CORP ($CTIC) and 10% Owner in XOMA Corp ($XOMA) and Director in XOMA Corp ($XOMA) and 10% Owner in ARQULE INC ($ARQL) and 10% Owner in INFINITY PHARMACEUTICALS, INC. ($INFI) and in FIVE PRIME THERAPEUTICS, INC. ($FPRX) and 10% Owner in FIVE PRIME THERAPEUTICS, INC. ($FPRX) and in CYTOKINETICS INC ($CYTK) and 10% Owner in CYTOKINETICS INC ($CYTK) and 10% Owner in GLYCOMIMETICS INC ($GLYC) and 10% Owner in CONCERT PHARMACEUTICALS, INC. ($CNCE) and 10% Owner in Syndax Pharmaceuticals Inc ($SNDX) and in Eledon Pharmaceuticals, Inc. ($NVUS) and in ChemoCentryx, Inc. ($CCXI) and 10% Owner in ChemoCentryx, Inc. ($CCXI) and 10% Owner in IMMUNE DESIGN CORP. ($IMDZ) and 10% Owner in Calithera Biosciences, Inc. ($CALA) and 10% Owner in Principia Biopharma Inc. ($PRNB) and 10% Owner in PIERIS PHARMACEUTICALS, INC. ($PIRS) and 10% Owner in Xenon Pharmaceuticals Inc. ($XENE) and 10% Owner in Nivalis Therapeutics, Inc. ($NVLS) and 10% Owner in Merus N.V. ($MRUS) and in IDEAYA Biosciences, Inc. ($IDYA) and 10% Owner in IDEAYA Biosciences, Inc. ($IDYA) and Director in Rain Therapeutics Inc. ($RAIN) and Director in Olema Pharmaceuticals, Inc. ($OLMA) and Director in Kymera Therapeutics, Inc. ($KYMR).
BVF PARTNERS L P/IL in PIERIS PHARMACEUTICALS, INC.
Trading Symbol: PIRSIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of BVF PARTNERS L P/IL: 10% Owner
Holdings: 2,385,055 shares
Current Value: $5,247,121
Latest Transaction: Sep 10 2019
$PIRS Market Capitalization: $91.71M
$PIRS Previous Close: $2.20
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of BVF PARTNERS L P/IL in PIERIS PHARMACEUTICALS, INC.
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ALPN, ARQL, CALA, CAPS, CCXI, CNCE, CTIC, CYTK, ELDN, FPRX, GLYC, IDYA, IMDZ, INFI, KYMR, MRUS, OLMA, PIRS, PRNB, RAIN, SNDX, XENE, XOMA
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Sep 10 2019 | PIRS | PIERIS PHARMACEUTI ... | BVF PARTNERS L P/IL | 10% Owner | Sell | S | 4.50 | 1,128 | 5,075 | 314,139 | 315.3 K to 314.1 K (-0.36 %) |
Sep 10 2019 | PIRS | PIERIS PHARMACEUTI ... | BVF PARTNERS L P/IL | 10% Owner | Sell | S | 4.50 | 25,720 | 115,725 | 2,233,074 | 2.3 M to 2.2 M (-1.14 %) |
Sep 10 2019 | PIRS | PIERIS PHARMACEUTI ... | BVF PARTNERS L P/IL | 10% Owner | Sell | S | 4.50 | 23,152 | 104,170 | 2,385,055 | 2.4 M to 2.4 M (-0.96 %) |
Feb 01 2019 | PIRS | PIERIS PHARMACEUTI ... | BVF PARTNERS L P/IL | 10% Owner | Option Exercise | J | 0.00 | 284 | 0 | 284 | |
Feb 01 2019 | PIRS | PIERIS PHARMACEUTI ... | BVF PARTNERS L P/IL | 10% Owner | Option Exercise | J | 0.00 | 2,143 | 0 | 2,143 | |
Feb 01 2019 | PIRS | PIERIS PHARMACEUTI ... | BVF PARTNERS L P/IL | 10% Owner | Option Exercise | J | 0.00 | 2,573 | 0 | 2,573 | |
Feb 01 2019 | PIRS | PIERIS PHARMACEUTI ... | BVF PARTNERS L P/IL | 10% Owner | Sell | J | 0.00 | 284,000 | 0 | 141,346 | 425.3 K to 141.3 K (-66.77 %) |
Feb 01 2019 | PIRS | PIERIS PHARMACEUTI ... | BVF PARTNERS L P/IL | 10% Owner | Sell | J | 0.00 | 2,143,000 | 0 | 772,324 | 2.9 M to 772.3 K (-73.51 %) |
Feb 01 2019 | PIRS | PIERIS PHARMACEUTI ... | BVF PARTNERS L P/IL | 10% Owner | Sell | J | 0.00 | 2,573,000 | 0 | 978,200 | 3.6 M to 978.2 K (-72.45 %) |
Page: 1